Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines
Lang Rao(Shenzhen Metro (China)), Shibo Jiang(Shanghai Medical College of Fudan University), Shuai Xia(Shanghai Medical College of Fudan University), Guocan Yu(Tsinghua University), Lu Lu(Shanghai Medical College of Fudan University), Youhua Xie(Shanghai Medical College of Fudan University), Pan Pan(Anqing Normal University), Rui Tian(Beijing Botanical Garden), Chenjian Gu(Washington University in St. Louis), Xia Cai(Fudan University), Qian-Fang Meng(Wuhan University), Wei Xu(Beijing Geriatric Hospital), Di Qu(Xijing Hospital)
Cited by 262
Related Papers
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
|Cell Research|2020|1.4k
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
|Cellular and Molecular Immunology|2020|759
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron
|RePEc: Research Papers in Economics|0|647
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
|Nature Communications|2014|400